Upregulation of DEPDC1B is inversely linked with patient survival in NSCLC and may increase tumor cell motility and invasion by activating Wnt/b-catenin signaling (31) and functioning as a potential biomarker. The gene discussed is DEPDC1B; the disease is non-small cell lung carcinoma.